Posts in category Insights


Tuesday’s Analyst Insights: Apple Inc. (AAPL), Alcobra Ltd (ADHD), Twitter Inc (TWTR)

U.S. stocks are under pressure in afternoon trading, weighing down by healthcare and financial stocks. Among …

Read more

Biotech Insights: Alcobra Ltd (ADHD), Biogen Inc (BIIB), Juno Therapeutics Inc (JUNO)

Alcobra Ltd  Alcobra Ltd (NASDAQ:ADHD) lost half of its value today after announcing that the …

Read more

These Analysts Neutral On Gilead Sciences, Inc. (GILD) Following Sell Side Meeting

Yesterday, Gilead Sciences, Inc. (NASDAQ:GILD) held an analyst event where management hosted a sell-side meeting …

Read more

Cowen Shines Light on Sarepta Therapeutics Inc (SRPT) Following Corporate Update

In a research report published Tuesday, Cowen analyst Ritu Baral reiterated an Outperform rating on …

Read more

Cantor Analyst Chimes In on Amarin Corporation plc (ADR) (AMRN) Following Corporate Update

In a research report published Tuesday, Cantor analyst Chiara Russo reiterated an Overweight rating on …

Read more

Cowen Top Analyst Weighs In On Merrimack Pharmaceuticals Inc (MACK) Following Cancer Drugs Deal with Ipsen

In a research report released today, Cowen analyst Eric Schmidt reiterated a Market Perform rating …

Read more

Canaccord Cuts Price Tag on AEterna Zentaris Inc. (USA) (AEZS) Following Doomed Macrilen Phase 3 Failure; Shares Fall 8%

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are sinking 8% after the firm announced what Canaccord …

Read more

FBR Weighs in on Volatile Stocks: Kite Pharma Inc (KITE) and Agile Therapeutics Inc (AGRX)

The biotech-verse was buzzing this week after Kite Pharma Inc (NASDAQ:KITE) submitted an IND application for …

Read more

BTIG Steps to Sidelines on Bancorp Inc (TBBK); Shares Fall 5%

BTIG analyst Mark Palmer is stepping left and downgrading Bancorp Inc (NASDAQ:TBBK) from a Buy to a …

Read more

Piper Jaffray Moves to the Sidelines and Slashes Price Target on Inotek Pharmaceuticals Corp (ITEK); Shares Crash 70%

Inotek Pharmaceuticals Corp (NASDAQ:ITEK) shares are on a rapid 70% descent after the firm announced …

Read more